Market share of major varicella vaccine manufacturers in China 2020
In 2020, Changchun BCHT Biotechnology was the largest varicella (chickenpox) vaccine manufacturer in China, accounting for 32.47 percent of the total lot released volume. Measles, mumps and rubella are common respiratory infectious diseases among children. As varicella vaccine was not included into the category one, which is managed by the Chinese government and free-of-charge, the coverage rate of varicella vaccine in China was relatively lower than in other developed countries.
